Identification of 23 new prostate cancer susceptibility loci using the iCOGS custom genotyping array

  • Rosalind A. Eeles*
  • , Ali Amin Al Olama
  • , Sara Benlloch
  • , Edward J. Saunders
  • , Daniel A. Leongamornlert
  • , Malgorzata Tymrakiewicz
  • , Maya Ghoussaini
  • , Craig Luccarini
  • , Joe Dennis
  • , Sarah Jugurnauth-Little
  • , The PRACTICAL (Prostate Cancer Association Group to Investigate Cancer-Associated Alterations in the Genome) Consortium
  • , Jyotsna Batra
  • *Corresponding author for this work

Research output: Contribution to journalArticleResearchpeer-review

Abstract

Prostate cancer is the most frequently diagnosed cancer in males in developed countries. To identify common prostate cancer susceptibility alleles, we genotyped 211,155 SNPs on a custom Illumina array (iCOGS) in blood DNA from 25,074 prostate cancer cases and 24,272 controls from the international PRACTICAL Consortium. Twenty-three new prostate cancer susceptibility loci were identified at genome-wide significance (P < 5 × 10 -8). More than 70 prostate cancer susceptibility loci, explaining ∼30% of the familial risk for this disease, have now been identified. On the basis of combined risks conferred by the new and previously known risk loci, the top 1% of the risk distribution has a 4.7-fold higher risk than the average of the population being profiled. These results will facilitate population risk stratification for clinical studies.
Original languageEnglish
Pages (from-to)385-391
Number of pages7
JournalNature Genetics
Volume45
Issue number4
DOIs
Publication statusPublished - 27 Mar 2013
Externally publishedYes

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Fingerprint

Dive into the research topics of 'Identification of 23 new prostate cancer susceptibility loci using the iCOGS custom genotyping array'. Together they form a unique fingerprint.

Cite this